Names and pronunciation
(moh-gam′-yoo-lih′-zoo-mab) Poteligeo
PDF page 908
Drug reference
(moh-gam′-yoo-lih′-zoo-mab) Poteligeo
PDF page 908
Func. class.: Antineoplastic
PDF page 908
USES: Cutaneous T-cell lymphoma (CTCL) (mycosis fungoides or Sézary syndrome) in those who have received at least 1 prior systemic therapy
PDF page 908
CONTRAINDICATIONS: Hyper- sensitivity, pregnancy
PDF page 909
DOSAGE AND ROUTES • Adult: IV 1 mg/kg on days 1, 8, 15, and 22 in cycle 1, then 1 mg/kg on days 1 and 15 in subsequent cycles until dis- ease progression; therapy cycles are re- peated q28days
PDF page 909
Available forms: Solution for injection 20 mg/5 mL
PDF page 909
• Adult: IV 1 mg/kg on days 1, 8, 15, and 22 in cycle 1, then 1 mg/kg on days 1 and 15 in subsequent cycles until dis- ease progression; therapy cycles are re- peated q28days
PDF page 909